Show simple item record

dc.contributor.authorPetralia, G
dc.contributor.authorKoh, D-M
dc.contributor.authorAttariwala, R
dc.contributor.authorBusch, JJ
dc.contributor.authorEeles, R
dc.contributor.authorKarow, D
dc.contributor.authorLo, GG
dc.contributor.authorMessiou, C
dc.contributor.authorSala, E
dc.contributor.authorVargas, HA
dc.contributor.authorZugni, F
dc.contributor.authorPadhani, AR
dc.date.accessioned2021-08-12T10:06:40Z
dc.date.available2021-08-12T10:06:40Z
dc.date.issued2021-06
dc.identifier.citationRadiology, 2021, 299 (3), pp. 494 - 507
dc.identifier.issn0033-8419
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4747
dc.identifier.eissn1527-1315en_US
dc.identifier.doi10.1148/radiol.2021201740en_US
dc.description.abstractAcknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license <i>Online supplemental material is available for this article.</i>
dc.formatPrint-Electronic
dc.format.extent494 - 507
dc.languageeng
dc.language.isoeng
dc.titleOncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening.
dc.typeJournal Article
rioxxterms.versionofrecord10.1148/radiol.2021201740
rioxxterms.licenseref.startdate2021-06en_US
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfRadiology
pubs.issue3
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume299en_US
pubs.embargo.termsNot known
icr.researchteamOncogenetics
icr.researchteamOncogeneticsen_US
dc.contributor.icrauthorMessiou, Christinaen
dc.contributor.icrauthorEeles, Rosalinden
dc.contributor.icrauthorKoh, Dow-Muen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record